Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-204484
Filing Date
2026-05-04
Accepted
2026-05-04 18:10:27
Documents
1
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3878
  Complete submission text file 0001193125-26-204484.txt   5339
Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Wheadon David E. (Reporting) CIK: 0001789507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-43254 | Film No.: 26939557

Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Issuer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)